Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Bellvitge (17)

2023

  1. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  2. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 94-102

  3. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  4. Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 7, pp. 422-429

  5. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

2022

  1. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Circulation, Vol. 146, Núm. 16, pp. 1196-1206

  2. Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography

    Coronary Artery Disease, Vol. 33, Núm. 8, pp. 609-617

2021

  1. Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 427-435

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

2019

  1. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

    Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2017

  1. Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR)

    Clinical Cardiology, Vol. 40, Núm. 8, pp. 580-585

2015

  1. Cost-effectiveness of a European ST-segment elevation myocardial infarction network: Results from the Catalan Codi Infart network

    BMJ Open, Vol. 5, Núm. 12

  2. Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

    EuroIntervention, Vol. 11, Núm. 3, pp. 336-342

2005

  1. Características y mortalidad del infarto agudo de miocardio tratado con intervencionismo coronario percutáneo primario en España. Resultados del Registro TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos)

    Revista Espanola de Cardiologia, Vol. 58, Núm. 4, pp. 341-350

  2. Manejo del síndrome coronario agudo sin elevación del segmento ST en España. Estudio DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal ESpañol)

    Revista Espanola de Cardiologia, Vol. 58, Núm. 3, pp. 244-252

  3. Tratamiento y evolución a corto plazo de los ancianos con infarto agudo de miocardio ingresados en hospitales con disponibilidad de angioplastia primaria. El Registro TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos)

    Revista Espanola de Cardiologia, Vol. 58, Núm. 4, pp. 351-358